Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic response-guided therapy for prevention of recurrent esophageal variceal bleeding
2007-002237-37Phase 4Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of isosorbide mononitrate and prazosin in esophageal varices and Cirrhosis (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoints: All-cause mortality and Bleeding-related mortality. Started Aug 2008; status: active.
02
Drugs
isosorbide mononitrateprazosin
03
Conditions
esophageal varicesCirrhosis
Beyond the preview
Go deeper on 2007-002237-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002237-37.